Treatment breakthroughs, improved screening approaches and other developments from recent studies. Treatment breakthroughs, improved screening approaches and other developments from recent studies.
Intravenous administration of anti-CTLA4 with anti-PD1 provides durable tumour responses but causes severe treatment-related adverse events in patients with cancer1.…